GFAP and Alzheimer disease: Immunofluorescent labeling revealed that 3xTg-AD mice showed a broad astrocytic activation, as demonstrated by the increased expression of GFAP, which co-localized with iNOS, in both hippocampus and cortex, as compared to WT mice (Figure 3).